Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2015 Aug 01;882:401-20. doi: 10.1124/mol.115.099291.
Show Gene links
Show Anatomy links
A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude).
Hammer H
,
Bader BM
,
Ehnert C
,
Bundgaard C
,
Bunch L
,
Hoestgaard-Jensen K
,
Schroeder OH
,
Bastlund JF
,
Gramowski-Voß A
,
Jensen AA
.
???displayArticle.abstract???
In the present study, we have elucidated the functional characteristics and mechanism of action of methaqualone (2-methyl-3-o-tolyl-4(3H)-quinazolinone, Quaalude), an infamous sedative-hypnotic and recreational drug from the 1960s-1970s. Methaqualone was demonstrated to be a positive allosteric modulator at human α1,2,3,5β2,3γ2S GABAA receptors (GABAARs) expressed in Xenopus oocytes, whereas it displayed highly diverse functionalities at the α4,6β1,2,3δ GABAAR subtypes, ranging from inactivity (α4β1δ), through negative (α6β1δ) or positive allosteric modulation (α4β2δ, α6β2,3δ), to superagonism (α4β3δ). Methaqualone did not interact with the benzodiazepine, barbiturate, or neurosteroid binding sites in the GABAAR. Instead, the compound is proposed to act through the transmembrane β((+))/α((-)) subunit interface of the receptor, possibly targeting a site overlapping with that of the general anesthetic etomidate. The negligible activities displayed by methaqualone at numerous neurotransmitter receptors and transporters in an elaborate screening for additional putative central nervous system (CNS) targets suggest that it is a selective GABAAR modulator. The mode of action of methaqualone was further investigated in multichannel recordings from primary frontal cortex networks, where the overall activity changes induced by the compound at 1-100 μM concentrations were quite similar to those mediated by other CNS depressants. Finally, the free methaqualone concentrations in the mouse brain arising from doses producing significant in vivo effects in assays for locomotion and anticonvulsant activity correlated fairly well with its potencies as a modulator at the recombinant GABAARs. Hence, we propose that the multifaceted functional properties exhibited by methaqualone at GABAARs give rise to its effects as a therapeutic and recreational drug.
BARCELO,
A clinical study of methaqualone: a new nonbarbiturate hypnotic.
1961, Pubmed
BARCELO,
A clinical study of methaqualone: a new nonbarbiturate hypnotic.
1961,
Pubmed
Bali,
Defining the propofol binding site location on the GABAA receptor.
2004,
Pubmed
,
Xenbase
Belelli,
Extrasynaptic GABAA receptors: form, pharmacology, and function.
2009,
Pubmed
Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase
Brickley,
Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.
2012,
Pubmed
Brown,
Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.
2002,
Pubmed
Campo-Soria,
Mechanism of action of benzodiazepines on GABAA receptors.
2006,
Pubmed
,
Xenbase
Chen,
11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors.
2014,
Pubmed
,
Xenbase
Chiara,
Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue.
2012,
Pubmed
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Costa,
A novel family of negative and positive allosteric modulators of NMDA receptors.
2010,
Pubmed
,
Xenbase
Dawson,
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.
2006,
Pubmed
,
Xenbase
Desai,
Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
2009,
Pubmed
,
Xenbase
Doran,
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model.
2005,
Pubmed
Falco,
Methaqualone misuse: foreign experience and United States drug control policy.
1976,
Pubmed
Feng,
Multiple actions of propofol on alphabetagamma and alphabetadelta GABAA receptors.
2004,
Pubmed
Feng,
Barbiturates require the N terminus and first transmembrane domain of the delta subunit for enhancement of alpha1beta3delta GABAA receptor currents.
2010,
Pubmed
Feng,
Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents.
2004,
Pubmed
Ghiani,
Biochemical evaluations of the effects of loreclezole and propofol on the GABAA receptor in rat brain.
1996,
Pubmed
Gielen,
Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding.
2012,
Pubmed
,
Xenbase
Gramowski,
Substance identification by quantitative characterization of oscillatory activity in murine spinal cord networks on microelectrode arrays.
2004,
Pubmed
Gramowski,
Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips.
2006,
Pubmed
Green,
A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor.
1996,
Pubmed
Greenfield,
Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement.
2002,
Pubmed
,
Xenbase
Halliwell,
Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid.
1999,
Pubmed
,
Xenbase
Herd,
Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors.
2007,
Pubmed
Herzberg,
Blockbusters and controlled substances: Miltown, Quaalude, and consumer demand for drugs in postwar America.
2011,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hicks,
Receptive-field size of S1 cortical neurones is altered by methaqualone via a GABA mechanism.
1990,
Pubmed
Hill-Venning,
Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor.
1997,
Pubmed
,
Xenbase
Hoestgaard-Jensen,
Probing α4βδ GABAA receptor heterogeneity: differential regional effects of a functionally selective α4β1δ/α4β3δ receptor agonist on tonic and phasic inhibition in rat brain.
2014,
Pubmed
,
Xenbase
Hoestgaard-Jensen,
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.
2013,
Pubmed
,
Xenbase
Hosie,
Conserved site for neurosteroid modulation of GABA A receptors.
2009,
Pubmed
Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed
Ionescu-Pioggia,
Methaqualone.
1988,
Pubmed
Jensen,
Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptors.
2010,
Pubmed
Jensen,
A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.
2013,
Pubmed
,
Xenbase
Johnstone,
Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century.
2010,
Pubmed
KIMBALL,
Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice.
1957,
Pubmed
Karim,
Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors.
2012,
Pubmed
,
Xenbase
Karim,
Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review.
2013,
Pubmed
,
Xenbase
Keov,
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
2011,
Pubmed
Khom,
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity.
2007,
Pubmed
,
Xenbase
Krasowski,
Methionine 286 in transmembrane domain 3 of the GABAA receptor beta subunit controls a binding cavity for propofol and other alkylphenol general anesthetics.
2001,
Pubmed
Lansdell,
Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
2015,
Pubmed
,
Xenbase
Lavé,
Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.
1999,
Pubmed
Li,
Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog.
2006,
Pubmed
Löscher,
Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations.
1988,
Pubmed
Marlo,
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
2009,
Pubmed
Mathiesen,
Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP.
2003,
Pubmed
McCarthy,
Treatment for methaqualone dependence in adults.
2005,
Pubmed
Meera,
Etomidate, propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant alpha4beta3delta and alpha4beta3 GABA A receptors expressed in HEK cells.
2009,
Pubmed
Mortensen,
GABA Potency at GABA(A) Receptors Found in Synaptic and Extrasynaptic Zones.
2011,
Pubmed
Mozrzymas,
Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors.
1999,
Pubmed
Mozrzymas,
Facilitation of miniature GABAergic currents by chlorpromazine in cultured rat hippocampal cells.
1999,
Pubmed
Müller,
Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes.
1978,
Pubmed
Naik,
Involvement of gamma-amino butyric acid (GABA) in the anticonvulsant action of methaqualone.
1978,
Pubmed
Novellino,
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals.
2011,
Pubmed
Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed
Parenti,
The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
2013,
Pubmed
Parry,
Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001).
2004,
Pubmed
Pfeiffer,
Quantitative analysis of the effect of methqualone on the human EEG.
1968,
Pubmed
Quast,
Modulation of [3H]muscimol binding in rat cerebellar and cerebral cortical membranes by picrotoxin, pentobarbitone, and etomidate.
1983,
Pubmed
Redrobe,
Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.
2012,
Pubmed
,
Xenbase
Sanacora,
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?
2015,
Pubmed
Sarantis,
Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus.
2008,
Pubmed
Sauguet,
Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel.
2013,
Pubmed
Saxena,
Electroencephalographic studies with i.v. methaqualone in man.
1977,
Pubmed
Serafini,
Structural domains of the human GABAA receptor 3 subunit involved in the actions of pentobarbital.
2000,
Pubmed
Sharma,
To scale or not to scale: the principles of dose extrapolation.
2009,
Pubmed
Sieghart,
Allosteric modulation of GABAA receptors via multiple drug-binding sites.
2015,
Pubmed
Siegwart,
Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors.
2002,
Pubmed
Sigel,
A closer look at the high affinity benzodiazepine binding site on GABAA receptors.
2011,
Pubmed
,
Xenbase
Slany,
Allosteric modulation of [3H]flunitrazepam binding to recombinant GABAA receptors.
1995,
Pubmed
Stanley,
The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.
2005,
Pubmed
Stewart,
Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.
2008,
Pubmed
,
Xenbase
Stewart,
Cysteine substitutions define etomidate binding and gating linkages in the α-M1 domain of γ-aminobutyric acid type A (GABAA) receptors.
2013,
Pubmed
,
Xenbase
Stewart,
Mutations at beta N265 in γ-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics.
2014,
Pubmed
,
Xenbase
Stórustovu,
Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.
2006,
Pubmed
,
Xenbase
Thompson,
Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.
2004,
Pubmed
,
Xenbase
Trattnig,
Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
2012,
Pubmed
Wafford,
Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.
2009,
Pubmed
Wafford,
A novel allosteric modulatory site on the GABAA receptor beta subunit.
1994,
Pubmed
,
Xenbase
Walters,
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms.
2000,
Pubmed
,
Xenbase
Whiting,
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
2003,
Pubmed
Wieland,
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
1992,
Pubmed
Wingrove,
The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.
1994,
Pubmed
,
Xenbase
Wooltorton,
Pharmacological and physiological characterization of murine homomeric beta3 GABA(A) receptors.
1997,
Pubmed
,
Xenbase
Xue,
Loreclezole modulates [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding via a distinct site on the GABAA receptor complex.
1996,
Pubmed
Zhong,
Interactions between loreclezole, chlormethiazole and pentobarbitone at GABA(A) receptors: functional and binding studies.
1997,
Pubmed
de Lucas,
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
2015,
Pubmed
,
Xenbase